{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:34:06Z","timestamp":1790728446207,"version":"4.1.0"},"reference-count":42,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T00:00:00Z","timestamp":1665446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T00:00:00Z","timestamp":1665446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"SPPH Incubator Fund for Development of Science and Technology","award":["2021YJY-19"],"award-info":[{"award-number":["2021YJY-19"]}]},{"name":"SPPH Foundation for Development of Science and Technology","award":["2021BJ-26"],"award-info":[{"award-number":["2021BJ-26"]}]},{"name":"Xi\u2019an Foundation for Development of Science and Technology","award":["20YXYJ0009(11)"],"award-info":[{"award-number":["20YXYJ0009(11)"]}]},{"DOI":"10.13039\/501100012326","name":"International Science and Technology Cooperation Programme","doi-asserted-by":"publisher","award":["2022KW-14"],"award-info":[{"award-number":["2022KW-14"]}],"id":[{"id":"10.13039\/501100012326","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Scientific and Technological Innovation Team of Shaanxi Province","award":["2021TD-40"],"award-info":[{"award-number":["2021TD-40"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Immunol. Ther. Exp."],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s00005-022-00663-8","type":"journal-article","created":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T14:02:41Z","timestamp":1665496961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Interleukin-35 has a Protective Role in Infectious Mononucleosis-Induced Liver Inflammation Probably by Inhibiting CD8+ T Cell Function"],"prefix":"10.2478","volume":"70","author":[{"given":"Ying","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1949-7737","authenticated-orcid":false,"given":"Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2022,10,11]]},"reference":[{"key":"663_CR1","doi-asserted-by":"publisher","first-page":"e1003220","DOI":"10.1371\/journal.ppat.1003220","volume":"9","author":"DF Angelini","year":"2013","unstructured":"Angelini DF, Serafini B, Piras E et al (2013) Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis. PLoS Pathog 9:e1003220. https:\/\/doi.org\/10.1371\/journal.ppat.1003220","journal-title":"PLoS Pathog"},{"key":"663_CR2","doi-asserted-by":"publisher","first-page":"e954893","DOI":"10.4161\/21624011.2014.954893","volume":"3","author":"S Boegel","year":"2014","unstructured":"Boegel S, Lower M, Bukur T et al (2014) A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines. Oncoimmunology 3:e954893. https:\/\/doi.org\/10.4161\/21624011.2014.954893","journal-title":"Oncoimmunology"},{"key":"663_CR3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.clim.2015.08.016","volume":"161","author":"J Cao","year":"2015","unstructured":"Cao J, Xu F, Lin S et al (2015) IL-35 is elevated in clinical and experimental sepsis and mediates inflammation. Clin Immunol 161:89\u201395. https:\/\/doi.org\/10.1016\/j.clim.2015.08.016","journal-title":"Clin Immunol"},{"key":"663_CR4","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.1182\/blood.2020009482","volume":"137","author":"Y Deng","year":"2021","unstructured":"Deng Y, Chatterjee B, Zens K et al (2021) CD27 is required for protective lytic EBV antigen-specific CD8+ T-cell expansion. Blood 137:3225\u20133236. https:\/\/doi.org\/10.1182\/blood.2020009482","journal-title":"Blood"},{"key":"663_CR5","doi-asserted-by":"publisher","first-page":"117663","DOI":"10.1016\/j.lfs.2020.117663","volume":"252","author":"Y Dong","year":"2020","unstructured":"Dong Y, Li X, Yu Y et al (2020) JAK\/STAT signaling is involved in IL-35-induced inhibition of hepatitis B virus antigen-specific cytotoxic T cell exhaustion in chronic hepatitis B. Life Sci 252:117663. https:\/\/doi.org\/10.1016\/j.lfs.2020.117663","journal-title":"Life Sci"},{"key":"663_CR6","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1182\/blood-2002-01-0160","volume":"100","author":"PJ Dunne","year":"2002","unstructured":"Dunne PJ, Faint JM, Gudgeon NH et al (2002) Epstein-Barr virus-specific CD8(+) T cells that re-express CD45RA are apoptosis-resistant memory cells that retain replicative potential. Blood 100:933\u2013940. https:\/\/doi.org\/10.1182\/blood-2002-01-0160","journal-title":"Blood"},{"key":"663_CR7","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1001\/jama.2016.2111","volume":"315","author":"MH Ebell","year":"2016","unstructured":"Ebell MH, Call M, Shinholser J et al (2016) Does this patient have infectious mononucleosis? The rational clinical examination systematic review. JAMA 315:1502\u20131509. https:\/\/doi.org\/10.1001\/jama.2016.2111","journal-title":"JAMA"},{"key":"663_CR8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/scientificamerican0779-48","volume":"241","author":"W Henle","year":"1979","unstructured":"Henle W, Henle G, Lennette ET (1979) The Epstein-Barr virus. Sci Am 241:48\u201359. https:\/\/doi.org\/10.1038\/scientificamerican0779-48","journal-title":"Sci Am"},{"key":"663_CR9","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/0002-9343(52)90154-x","volume":"13","author":"RJ Hoagland","year":"1952","unstructured":"Hoagland RJ (1952) Infectious mononucleosis. Am J Med 13:158\u2013171. https:\/\/doi.org\/10.1016\/0002-9343(52)90154-x","journal-title":"Am J Med"},{"key":"663_CR10","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1186\/s12879-018-3488-8","volume":"18","author":"J Hu","year":"2018","unstructured":"Hu J, Zhao H, Lou D et al (2018) Human cytomegalovirus and Epstein-Barr virus infections, risk factors, and their influence on the liver function of patients with acute-on-chronic liver failure. BMC Infect Dis 18:577. https:\/\/doi.org\/10.1186\/s12879-018-3488-8","journal-title":"BMC Infect Dis"},{"key":"663_CR11","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1089\/jir.2017.0080","volume":"37","author":"Q Huang","year":"2017","unstructured":"Huang Q, Wang Y, Si C et al (2017) Interleukin-35 modulates the imbalance between regulatory T cells and T helper 17 cells in enterovirus 71-induced hand, foot, and mouth disease. J Interferon Cytokine Res 37:522\u2013530. https:\/\/doi.org\/10.1089\/jir.2017.0080","journal-title":"J Interferon Cytokine Res"},{"key":"663_CR12","doi-asserted-by":"publisher","first-page":"105907","DOI":"10.1016\/j.intimp.2019.105907","volume":"76","author":"B Jin","year":"2019","unstructured":"Jin B, Liang Y, Liu Y et al (2019) Notch signaling pathway regulates T cell dysfunction in septic patients. Int Immunopharmacol 76:105907. https:\/\/doi.org\/10.1016\/j.intimp.2019.105907","journal-title":"Int Immunopharmacol"},{"key":"663_CR13","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1073\/pnas.0538056100","volume":"100","author":"BJ Johnson","year":"2003","unstructured":"Johnson BJ, Costelloe EO, Fitzpatrick DR et al (2003) Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virus-infected mice. Proc Natl Acad Sci USA 100:2657\u20132662. https:\/\/doi.org\/10.1073\/pnas.0538056100","journal-title":"Proc Natl Acad Sci USA"},{"key":"663_CR14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4997\/JRCPE.2021.111","volume":"51","author":"T Kamal","year":"2021","unstructured":"Kamal T, Haboubi N (2021) Epstein-Barr virus and acute liver failure: an exceedingly rare amalgamation. J R Coll Physicians Edinb 51:46\u201348. https:\/\/doi.org\/10.4997\/JRCPE.2021.111","journal-title":"J R Coll Physicians Edinb"},{"key":"663_CR15","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1186\/s12889-020-09049-x","volume":"20","author":"A Kuri","year":"2020","unstructured":"Kuri A, Jacobs BM, Vickaryous N et al (2020) Epidemiology of Epstein-Barr virus infection and infectious mononucleosis in the United Kingdom. BMC Public Health 20:912. https:\/\/doi.org\/10.1186\/s12889-020-09049-x","journal-title":"BMC Public Health"},{"key":"663_CR16","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1042\/CS20140511","volume":"129","author":"X Li","year":"2015","unstructured":"Li X, Tian L, Dong Y et al (2015) IL-35 inhibits HBV antigen-specific IFN-gamma-producing CTLs in vitro. Clin Sci 129:395\u2013404. https:\/\/doi.org\/10.1042\/CS20140511","journal-title":"Clin Sci"},{"key":"663_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.intimp.2017.06.015","volume":"50","author":"S Liu","year":"2017","unstructured":"Liu S, Zhang Q, Shao X et al (2017) An immunosuppressive function of interleukin-35 in chronic hepatitis C virus infection. Int Immunopharmacol 50:87\u201394. https:\/\/doi.org\/10.1016\/j.intimp.2017.06.015","journal-title":"Int Immunopharmacol"},{"key":"663_CR18","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/cei.13535","volume":"203","author":"X Liu","year":"2021","unstructured":"Liu X, Ren H, Guo H et al (2021) Interleukin-35 has a tumor-promoting role in hepatocellular carcinoma. Clin Exp Immunol 203:219\u2013229. https:\/\/doi.org\/10.1111\/cei.13535","journal-title":"Clin Exp Immunol"},{"key":"663_CR19","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1007\/s10620-014-3029-2","volume":"59","author":"JL Mellinger","year":"2014","unstructured":"Mellinger JL, Rossaro L, Naugler WE et al (2014) Epstein-Barr virus (EBV) related acute liver failure: a case series from the US Acute Liver Failure Study Group. Dig Dis Sci 59:1630\u20131637. https:\/\/doi.org\/10.1007\/s10620-014-3029-2","journal-title":"Dig Dis Sci"},{"key":"663_CR20","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.4049\/jimmunol.1900422","volume":"203","author":"P Naluyima","year":"2019","unstructured":"Naluyima P, Lal KG, Costanzo MC et al (2019) Terminal effector CD8 T cells defined by an IKZF2(+)IL-7R(\u2212) transcriptional signature express FcgammaRIIIA, expand in HIV infection, and mediate potent HIV-specific antibody-dependent cellular cytotoxicity. J Immunol 203:2210\u20132221. https:\/\/doi.org\/10.4049\/jimmunol.1900422","journal-title":"J Immunol"},{"key":"663_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1080\/09674845.2021.1903683","volume":"78","author":"P Naughton","year":"2021","unstructured":"Naughton P, Healy M, Enright F et al (2021) Infectious mononucleosis: diagnosis and clinical interpretation. Br J Biomed Sci 78:107\u2013116. https:\/\/doi.org\/10.1080\/09674845.2021.1903683","journal-title":"Br J Biomed Sci"},{"key":"663_CR22","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1056\/NEJM197606172942501","volume":"294","author":"JC Niederman","year":"1976","unstructured":"Niederman JC, Miller G, Pearson HA et al (1976) Infectious mononucleosis. Epstein-Barr-virus shedding in saliva and the oropharynx. N Engl J Med 294:1355\u20131359. https:\/\/doi.org\/10.1056\/NEJM197606172942501","journal-title":"N Engl J Med"},{"key":"663_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.5114\/ceji.2016.65892","volume":"42","author":"H Ouyang","year":"2017","unstructured":"Ouyang H, Xiang L, Chen J et al (2017) Significant reduction of peripheral blood interleukin-35 and CD4(+)EBI3(+) T cells, which are negatively correlated with an increase in the plasma IL-17 and cTnI level, in viral myocarditis patients. Cent Eur J Immunol 42:91\u201396. https:\/\/doi.org\/10.5114\/ceji.2016.65892","journal-title":"Cent Eur J Immunol"},{"key":"663_CR24","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1093\/infdis\/jiv340","volume":"212","author":"A Panikkar","year":"2015","unstructured":"Panikkar A, Smith C, Hislop A et al (2015) Cytokine-mediated loss of blood dendritic cells during Epstein-Barr virus-associated acute infectious mononucleosis: implication for immune dysregulation. J Infect Dis 212:957\u20131961. https:\/\/doi.org\/10.1093\/infdis\/jiv340","journal-title":"J Infect Dis"},{"key":"663_CR25","doi-asserted-by":"publisher","first-page":"287","DOI":"10.4049\/jimmunol.0902761","volume":"184","author":"S Phillips","year":"2010","unstructured":"Phillips S, Chokshi S, Riva A et al (2010) CD8(+) T cell control of hepatitis B virus replication: direct comparison between cytolytic and noncytolytic functions. J Immunol 184:287\u2013295. https:\/\/doi.org\/10.4049\/jimmunol.0902761","journal-title":"J Immunol"},{"key":"663_CR26","doi-asserted-by":"publisher","first-page":"e0253005","DOI":"10.1371\/journal.pone.0253005","volume":"16","author":"S Rahman","year":"2021","unstructured":"Rahman S, Wathington D, Waterboer T et al (2021) Seroprevalence of Chlamydia trachomatis, herpes simplex 2, Epstein-Barr virus, hepatitis C and associated factors among a cohort of men ages 18\u201370 years from three countries. PLoS ONE 16:e0253005. https:\/\/doi.org\/10.1371\/journal.pone.0253005","journal-title":"PLoS ONE"},{"key":"663_CR27","doi-asserted-by":"publisher","first-page":"773983","DOI":"10.3389\/fimmu.2021.773983","volume":"12","author":"LS Rodrigues","year":"2021","unstructured":"Rodrigues LS, Barreto AS, Bomfim LGS et al (2021) Multifunctional, TNF-alpha and IFN-gamma-Secreting CD4 and CD8 T cells and CD8(high) T cells are associated with the cure of human visceral Leishmaniasis. Front Immunol 12:773983. https:\/\/doi.org\/10.3389\/fimmu.2021.773983","journal-title":"Front Immunol"},{"key":"663_CR28","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3389\/fcimb.2017.00472","volume":"7","author":"X Shao","year":"2017","unstructured":"Shao X, Ma J, Jia S et al (2017) Interleukin-35 suppresses antiviral immune response in chronic hepatitis B virus infection. Front Cell Infect Microbiol 7:472. https:\/\/doi.org\/10.3389\/fcimb.2017.00472","journal-title":"Front Cell Infect Microbiol"},{"key":"663_CR29","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.advms.2014.04.003","volume":"59","author":"A Sulik","year":"2014","unstructured":"Sulik A, Oldak E, Kroten A et al (2014) Epstein-Barr virus effect on frequency of functionally distinct T cell subsets in children with infectious mononucleosis. Adv Med Sci 59:227\u2013231. https:\/\/doi.org\/10.1016\/j.advms.2014.04.003","journal-title":"Adv Med Sci"},{"key":"663_CR30","doi-asserted-by":"publisher","first-page":"107642","DOI":"10.1016\/j.intimp.2021.107642","volume":"96","author":"M Sun","year":"2021","unstructured":"Sun M, Xing H (2021) Interleukin-35 regulates peripheral T cell activity in patients with Kawasaki disease. Int Immunopharmacol 96:107642. https:\/\/doi.org\/10.1016\/j.intimp.2021.107642","journal-title":"Int Immunopharmacol"},{"key":"663_CR31","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1684\/ecn.2020.0455","volume":"31","author":"A Taghinejad","year":"2020","unstructured":"Taghinejad A, Barani S, Gholijani N et al (2020) Variations in IL-22, IL-27 and IL-35 serum levels in untreated and treated hepatitis C patients. Eur Cytokine Netw 31:134\u2013139. https:\/\/doi.org\/10.1684\/ecn.2020.0455","journal-title":"Eur Cytokine Netw"},{"key":"663_CR32","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.intimp.2019.02.048","volume":"70","author":"DK Teng","year":"2019","unstructured":"Teng DK, Liu Y, Lv YF et al (2019) Elevated interleukin-35 suppresses liver inflammation by regulation of T helper 17 cells in acute hepatitis B virus infection. Int Immunopharmacol 70:252\u2013259. https:\/\/doi.org\/10.1016\/j.intimp.2019.02.048","journal-title":"Int Immunopharmacol"},{"key":"663_CR33","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1002\/ijc.31382","volume":"143","author":"M Teymouri","year":"2018","unstructured":"Teymouri M, Pirro M, Fallarino F et al (2018) IL-35, a hallmark of immune-regulation in cancer progression, chronic infections and inflammatory diseases. Int J Cancer 143:2105\u20132115. https:\/\/doi.org\/10.1002\/ijc.31382","journal-title":"Int J Cancer"},{"key":"663_CR34","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1365-2036.2012.05122.x","volume":"36","author":"LJ Vine","year":"2012","unstructured":"Vine LJ, Shepherd K, Hunter JG et al (2012) Characteristics of Epstein-Barr virus hepatitis among patients with jaundice or acute hepatitis. Aliment Pharmacol Ther 36:16\u201321. https:\/\/doi.org\/10.1111\/j.1365-2036.2012.05122.x","journal-title":"Aliment Pharmacol Ther"},{"key":"663_CR35","doi-asserted-by":"publisher","first-page":"108915","DOI":"10.1016\/j.clim.2021.108915","volume":"235","author":"D Wu","year":"2022","unstructured":"Wu D, Wang L, Hong D et al (2022) Interleukin 35 contributes to immunosuppression by regulating inflammatory cytokines and T cell populations in the acute phase of sepsis. Clin Immunol 235:108915. https:\/\/doi.org\/10.1016\/j.clim.2021.108915","journal-title":"Clin Immunol"},{"key":"663_CR36","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12985-019-1158-0","volume":"16","author":"L Yang","year":"2019","unstructured":"Yang L, Jia S, Shao X et al (2019a) Interleukin-35 modulates the balance between viral specific CD4(+)CD25(+)CD127(dim\/-) regulatory T cells and T helper 17 cells in chronic hepatitis B virus infection. Virol J 16:48. https:\/\/doi.org\/10.1186\/s12985-019-1158-0","journal-title":"Virol J"},{"key":"663_CR37","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.3389\/fimmu.2019.01032","volume":"10","author":"L Yang","year":"2019","unstructured":"Yang L, Shao X, Jia S et al (2019b) Interleukin-35 dampens CD8(+) T cells activity in patients with non-viral hepatitis-related hepatocellular carcinoma. Front Immunol 10:1032. https:\/\/doi.org\/10.3389\/fimmu.2019.01032","journal-title":"Front Immunol"},{"key":"663_CR38","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.1007\/s10620-020-06077-w","volume":"65","author":"L Yang","year":"2020","unstructured":"Yang L, Zhang Q, Song J et al (2020) Interleukin-35 suppresses CD8(+) T cell activity in patients with viral hepatitis-induced acute-on-chronic liver failure. Dig Dis Sci 65:3614\u20133623. https:\/\/doi.org\/10.1007\/s10620-020-06077-w","journal-title":"Dig Dis Sci"},{"key":"663_CR39","doi-asserted-by":"publisher","first-page":"120","DOI":"10.5114\/wo.2014.44754","volume":"19","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Sun H, Wu H et al (2015) Interleukin 35 is an independent prognostic factor and a therapeutic target for nasopharyngeal carcinoma. Contemp Oncol 19:120\u2013124. https:\/\/doi.org\/10.5114\/wo.2014.44754","journal-title":"Contemp Oncol"},{"key":"663_CR40","doi-asserted-by":"publisher","first-page":"9273241","DOI":"10.1155\/2020\/9273241","volume":"2020","author":"W Zhang","year":"2020","unstructured":"Zhang W, Huang Z, Huang M et al (2020) Predicting severe enterovirus 71-infected hand, foot, and mouth disease: cytokines and chemokines. Mediators Inflamm 2020:9273241. https:\/\/doi.org\/10.1155\/2020\/9273241","journal-title":"Mediators Inflamm"},{"key":"663_CR41","doi-asserted-by":"publisher","first-page":"809005","DOI":"10.3389\/fped.2021.809005","volume":"9","author":"C Zhang","year":"2021","unstructured":"Zhang C, Cui S, Mao G et al (2021a) Clinical characteristics and the risk factors of hepatic injury in 221 children with infectious mononucleosis. Front Pediatr 9:809005. https:\/\/doi.org\/10.3389\/fped.2021.809005","journal-title":"Front Pediatr"},{"key":"663_CR42","doi-asserted-by":"publisher","first-page":"645835","DOI":"10.3389\/fimmu.2021.645835","volume":"12","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Yang L, Liu S et al (2021b) Interleukin-35 suppresses interleukin-9-secreting CD4(+) T cell activity in patients with hepatitis B-related hepatocellular carcinoma. Front Immunol 12:645835. https:\/\/doi.org\/10.3389\/fimmu.2021.645835","journal-title":"Front Immunol"}],"container-title":["Archivum Immunologiae et Therapiae Experimentalis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-022-00663-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00005-022-00663-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-022-00663-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T20:49:54Z","timestamp":1704228594000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00005-022-00663-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,11]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["663"],"URL":"https:\/\/doi.org\/10.1007\/s00005-022-00663-8","relation":{},"ISSN":["0004-069X","1661-4917"],"issn-type":[{"value":"0004-069X","type":"print"},{"value":"1661-4917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,11]]},"assertion":[{"value":"2 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare no conflicts of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The current study protocol was in accordance with the Declaration of Helsinki, and was approved by the Ethics Committee of Shaanxi Provincial People\u2019s Hospital (No. 2017019).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written consent was obtained from each enrolled subject.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"25"}}